areds2.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-Agent: *
Meta Tags
Title An AREDS 2 Informational Website: AREDS 2 study questions, products and
Description The AREDS2.com website provides valuable information on learning all about the AREDS 2 Study results, the suggested eye vitamin formula for optimal results in fighting age related macular degeneration, and where you can find customer recommended
Keywords areds 2, areds2.com, areds 2 study, areds 2 study results, areds 2 formula, areds 2 products, areds 2 vitamin, areds 2 products, areds 2 softgel, areds, ared, age related eye disease study, macular degeneration, eye vitamins
Server Information
WebSite areds2 faviconareds2.com
Host IP 166.62.108.22
Location United States
Related Websites
Site Rank
More to Explore
areds2.com Valuation
US$292,071
Last updated: 2023-05-14 21:57:40

areds2.com has Semrush global rank of 36,238,900. areds2.com has an estimated worth of US$ 292,071, based on its estimated Ads revenue. areds2.com receives approximately 33,701 unique visitors each day. Its web server is located in United States, with IP address 166.62.108.22. According to SiteAdvisor, areds2.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$292,071
Daily Ads Revenue US$270
Monthly Ads Revenue US$8,089
Yearly Ads Revenue US$97,058
Daily Unique Visitors 2,247
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
areds2.com. A 599 IP: 166.62.108.22
areds2.com. NS 3600 NS Record: ns05.domaincontrol.com.
areds2.com. NS 3600 NS Record: ns06.domaincontrol.com.
HtmlToTextCheckTime:2023-05-14 21:57:40
AREDS 2 - Macular Degeneration Vitamins Home What is AREDS 2 Study? What is AMD? AREDS 2 Products Blog An AREDS 2 Informational Website The 2013 National Eye Institutes five year AREDS 2 study (Age-Related Eye Disease Study) proved that a revised formula consisting of the AREDS formula without beta-carotene, adding lutein and zeaxanthin reduces the risk of progression of Age-Related Macular Degeneration by an additional eighteen percent compared to those in the AREDS 2 study who took the original recommended formula from 2001. The subset of participants that took lutein and zeaxanthin and no beta-carotene reduced their risk of developing advanced stages of AMD by 18% compared to the those in AREDS 2 who took the original supplement with beta carotene. Furthermore the study showed that in 5 years the participants that took the new formula to have less risk of progression of AMD than the people that took the original formula. In fact, the AREDS 2 formula information proved to decrease
HTTP Headers
HTTP/1.1 200 OK
Accept-Ranges: bytes
Age: 62786
Content-Length: 16136
Content-Type: text/html; charset=UTF-8
Date: Thu, 23 Dec 2021 09:01:31 GMT
Vary: Accept-Encoding, User-Agent
X-Backend: local
X-Cache: cached
X-Cache-Hit: HIT
X-Cacheable: YES:Forced
X-Content-Type-Options: nosniff
X-Pingback: http://areds2.com/xmlrpc.php
X-Xss-Protection: 1; mode=block
areds2.com Whois Information
Domain Name: AREDS2.COM
Registry Domain ID: 218242606_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-05-28T22:10:08Z
Creation Date: 2005-09-28T12:41:22Z
Registry Expiry Date: 2023-06-02T03:59:59Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS05.DOMAINCONTROL.COM
Name Server: NS06.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-27T08:08:59Z <<<